Sp1 upregulates the Four and Half Lim 2 (FHL2) expression in gastrointestinal cancers through transcription regulation

Molecular Carcinogenesis

Volumn 49, Issue 9, 2010, Pages 826-836

  Guo, Zheng ^a   Zhang, Wenjing ^a   Xia, Guosheng ^a   Niu, Lingyun ^a   Zhang, Yan ^a   Wang, Xinying ^a   Zhang, Yali ^a   Jiang, Bo ^a   Wang, Jide ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Cancer; Gastrointestinal; Transcriptional regulation

Indexed keywords

FOUR AND HALF LIM 2 PROTEIN; INHIBITOR PROTEIN; MITHRAMYCIN A; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; NUCLEAR PROTEIN;

ARTICLE; BIOINFORMATICS; CANCER CELL; CANCER INHIBITION; CODON; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION; GASTROINTESTINAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; TRANSCRIPTION INITIATION; UPREGULATION;

BASE SEQUENCE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GASTROINTESTINAL NEOPLASMS; GENE EXPRESSION REGULATION; HUMANS; NUCLEAR PROTEINS; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 77956212105     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20659     Document Type: Article

References (35)

1. Kadrmas JL, Beckerle MC. The LIM domain: From the cytoskeleton to the nucleus. Nat Rev Mol Cell Biol 2004;5:920-931.
2. Purcell NH, Darwis D, Bueno OF, Muller JM, Schule R, Molkentin JD. Extracellular signal-regulated kinase 2 interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytes. Mol Cell Biol 2004;24:1081-1095.
3. Wang J, Yang Y, Xia HH, et al. Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis. Gastroenterology 2007;132:1066-1076.
4. Genini M, Schwalbe P, Scholl FA, Remppis A, Mattei MG, Schafer BW. Subtractive cloning and characterization of DRAL, a novel LIM-domain protein down-regulated in rhabdomyosarcoma. DNA Cell Biol 1997;16:433-442.
5. Johannessen M, Moller S, Hansen T, Moens U, van Ghelue M. The multifunctional roles of the four-and-a-half-LIM only protein FHL2. Cell Mol Life Sci 2006;63:268-284. (Pubitemid 43202310)
6. Müller JM, Metzger E, Greschik H, et al. The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus. EMBO J 2002;21:736-748.
7. Wei Y, Renard CA, Labalette C, et al. Identification of the LIM protein FHL2 as a coactivator of beta-catenin. J Biol Chem 2003;278:5188-5194.
8. Morlon A, Sassone-Corsi P. The LIM-only protein FHL2 is a serum-inducible transcriptional coactivator of AP-1. Proc Natl Acad Sci USA 2003;100:3977-3982.
9. Scholl FA, McLoughlin P, Ehler E, de Giovanni C, Schäfer BW. DRAL is a p53-responsive gene whose four and a half LIM domain protein product induces apoptosis. J Cell Biol 2000;151:495-506.
10. Philippar U, Schratt G, Dieterich C, et al. The SRF target gene Fhl2 antagonizes RhoA/MAL-dependent activation of SRF. Mol Cell 2004;16:867-880.
11. Dynan WS, Tjian R. The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell 1983;35:79-87. (Pubitemid 14240221)
12. Narayan VA, Kriwacki RW, Caradonna JP. Structures of zinc finger domains from transcription factor Sp1. Insights into sequence-specific protein-DNA recognition. J Biol Chem 1997;272:7801-7809.
13. Saffer JD, Jackson SP, Annarella MB. Developmental expression of Sp1 in the mouse. Mol Cell Biol 1991;11:2189-2199.
14. Wang L, Wei D, Huang S, et al. Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin Cancer Res 2003;9:6371-6380.
15. Zannetti A, Del VS, Carriero MV, et al. Coordinate upregulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma. Cancer Res 2000;60:1546-1551.
16. Safe S, Abdelrahim M. Sp transcription factor family and its role in cancer. Eur J Cancer 2005;41:2438-2448. (Pubitemid 41540621)
17. Black AR, Black JD, Azizkhan-Clifford J. Sp1 and krüppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 2001;188:143-160.
18. Abdelrahim M, Smith R III, Burghardt R, Safe S. Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells. Cancer Res 2004;64:6740-6749.
19. Chiefari E, Brunetti A, Arturi F, et al. Increased expression of AP2 and Sp1 transcription factors in human thyroid tumors: A role in NIS expression regulation? BMC Cancer 2002;2:35.
20. Deutsch AJ, Aigelsreiter A, Steinbauer E, et al. Distinct signatures of B-cell homeostatic and activation-dependent chemokine receptors in the development and progression of extragastric MALT lymphomas. J Pathol 2008;215:431-444.
21. Wang J, Peng Y, Sun YW, et al. All-trans retinoic acid induces XAF1 expression through an interferon regulatory factor-1 element in colon cancer. Gastroenterology 2006;130:747-758.
22. Yuan P, Wang L, Wei D, et al. Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer. Cancer 2007;110:2682-2690.
23. Yu CX, Jin T, Chen WW, et al. Identification of Sp1-elements in the promoter region of human homeobox gene NKX3.1. Mol Biol Rep 2009;36:2353-2360.
24. Tang W, Pan Q, Sun F, et al. Involvement of Sp1 binding sequences in basal transcription of the rat fibroblast growth factor-2 gene in neonatal cardiomyocytes. Life Sci 2009;84:421-427.
25. Oguariri RM, Brann TW, Imamichi T. Hydroxyurea and interleukin-6 synergistically reactivate HIV-1 replication in a latently infected promonocytic cell line via SP1/SP3 transcription factors. J Biol Chem 2007;282:3594-3604.
26. Ding L, Wang Z, Yan J, et al. Human four-and-a-half LIM family members suppress tumor cell growth through a TGFbeta-like signaling pathway. J Clin Invest 2009;119:349-361.
27. Heemers HV, Regan KM, Dehm SM, Tindall DJ. Androgen induction of the androgen receptor coactivator four and a half LIM domain protein-2: Evidence for a role for serum response factor in prostate cancer. Cancer Res 2007;67:10592-10599.
28. Chatterjee S, Zaman K, Ryu H, Conforto A, Ratan RR. Sequence-selective DNA binding drugs mithramycin A and chromomycin A3 are potent inhibitors of neuronal apoptosis induced by oxidative stress and DNA damage in cortical neurons. Ann Neurol 2001;49:345-354.
29. Jungert K, Buck A, Buchholz M, et al. Smad-Sp1 complexes mediate TGFbeta-induced early transcription of oncogenic Smad7 in pancreatic cancer cells. Carcinogenesis 2006;27:2392-2401. (Pubitemid 44884096)
30. Yao JC, Wang L, Wei D, et al. Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer. Clin Cancer Res 2004;10:4109-4117.
31. Hosoi Y, Watanabe T, Nakagawa K, et al. Up-regulation of DNA-dependent protein kinase activity and Sp1 in colorectal cancer. Int J Oncol 2004;25:461-468.
32. Schewe DM, Biller T, Maurer G, et al. Combination analysis of activator protein-1 family members, Sp1 and an activator protein-2alpha-related factor binding to different regions of the urokinase receptor gene in resected colorectal cancers. Clin Cancer Res 2005;11:8538-8548.
33. Maurer GD, Leupold JH, Schewe DM, et al. Analysis of specific transcriptional regulators as early predictors of independent prognostic relevance in resected colorectal cancer. Clin Cancer Res 2007;13:1123-1132.
34. Jiang NY, Woda BA, Banner BF, Whalen GF, Dresser KA, Lu D. Sp1, a new biomarker that identifies a subset of aggressive pancreatic ductal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 2008;17:1648-1652.
35. Li M, Wang J, Ng SS, et al. The four-and-a-half-LIM protein 2 (FHL2) is overexpressed in gliomas and associated with oncogenic activities. Glia 2008;56:1328-1338.